183 related articles for article (PubMed ID: 30137467)
1. Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort.
Swerdlow AJ; Cooke R; Beckers D; Butler G; Carel JC; Cianfarani S; Clayton P; Coste J; Deodati A; Ecosse E; Hokken-Koelega ACS; Khan AJ; Kiess W; Kuehni CE; Flück CE; Pfaffle R; Sävendahl L; Sommer G; Thomas M; Tidblad A; Tollerfield S; Zandwijken GRJ
J Clin Endocrinol Metab; 2019 Mar; 104(3):658-664. PubMed ID: 30137467
[TBL] [Abstract][Full Text] [Related]
2. Influence of growth hormone therapy on the occurrence of a second neoplasm in survivors of childhood cancer.
Thomas-Teinturier C; Oliver-Petit I; Pacquement H; Fresneau B; Allodji RS; Veres C; Bolle S; Berchery D; Demoor-Goldschmidt C; Haddy N; Diallo I; de Vathaire F
Eur J Endocrinol; 2020 Oct; 183(4):471-480. PubMed ID: 32738133
[TBL] [Abstract][Full Text] [Related]
3. Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study.
Swerdlow AJ; Cooke R; Beckers D; Borgström B; Butler G; Carel JC; Cianfarani S; Clayton P; Coste J; Deodati A; Ecosse E; Gausche R; Giacomozzi C; Hokken-Koelega ACS; Khan AJ; Kiess W; Kuehni CE; Mullis PE; Pfaffle R; Sävendahl L; Sommer G; Thomas M; Tidblad A; Tollerfield S; Van Eycken L; Zandwijken GRJ
J Clin Endocrinol Metab; 2017 May; 102(5):1661-1672. PubMed ID: 28187225
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study.
Patterson BC; Chen Y; Sklar CA; Neglia J; Yasui Y; Mertens A; Armstrong GT; Meadows A; Stovall M; Robison LL; Meacham LR
J Clin Endocrinol Metab; 2014 Jun; 99(6):2030-7. PubMed ID: 24606096
[TBL] [Abstract][Full Text] [Related]
5. Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study.
Sävendahl L; Maes M; Albertsson-Wikland K; Borgström B; Carel JC; Henrard S; Speybroeck N; Thomas M; Zandwijken G; Hokken-Koelega A
J Clin Endocrinol Metab; 2012 Feb; 97(2):E213-7. PubMed ID: 22238393
[TBL] [Abstract][Full Text] [Related]
6. Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone.
Swerdlow AJ; Cooke R; Albertsson-Wikland K; Borgström B; Butler G; Cianfarani S; Clayton P; Coste J; Deodati A; Ecosse E; Gausche R; Giacomozzi C; Kiess W; Hokken-Koelega AC; Kuehni CE; Landier F; Maes M; Mullis PE; Pfaffle R; Sävendahl L; Sommer G; Thomas M; Tollerfield S; Zandwijken GR; Carel JC
Horm Res Paediatr; 2015; 84(3):172-83. PubMed ID: 26227295
[TBL] [Abstract][Full Text] [Related]
7. High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia.
Goshen Y; Stark B; Kornreich L; Michowiz S; Feinmesser M; Yaniv I
Pediatr Blood Cancer; 2007 Sep; 49(3):294-7. PubMed ID: 17243137
[TBL] [Abstract][Full Text] [Related]
8. Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age.
Kok JL; Teepen JC; van Leeuwen FE; Tissing WJE; Neggers SJCMM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; van den Heuvel-Eibrink MM; van Dulmen-den Broeder E; van der Heiden-van der Loo M; Aleman BMP; Daniels LA; Haasbeek CJA; Hoeben B; Janssens GO; Maduro JH; Oldenburger F; van Rij C; Tersteeg RJHA; Hauptmann M; ; Kremer LCM; Ronckers CM
Neuro Oncol; 2019 Feb; 21(3):392-403. PubMed ID: 30099534
[TBL] [Abstract][Full Text] [Related]
9. Morbidity and Mortality Associated With Meningioma After Cranial Radiotherapy: A Report From the Childhood Cancer Survivor Study.
Bowers DC; Moskowitz CS; Chou JF; Mazewski CM; Neglia JP; Armstrong GT; Leisenring WM; Robison LL; Oeffinger KC
J Clin Oncol; 2017 May; 35(14):1570-1576. PubMed ID: 28339329
[TBL] [Abstract][Full Text] [Related]
10. Meningiomas after cranial radiotherapy for childhood cancer: a single institution experience.
Felicetti F; Fortunati N; Garbossa D; Biasin E; Rudà R; Daniele D; Arvat E; Corrias A; Fagioli F; Brignardello E
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1277-82. PubMed ID: 25609074
[TBL] [Abstract][Full Text] [Related]
11. Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study.
Carel JC; Ecosse E; Landier F; Meguellati-Hakkas D; Kaguelidou F; Rey G; Coste J
J Clin Endocrinol Metab; 2012 Feb; 97(2):416-25. PubMed ID: 22238382
[TBL] [Abstract][Full Text] [Related]
12. Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program.
Child CJ; Zimmermann AG; Chrousos GP; Cummings E; Deal CL; Hasegawa T; Jia N; Lawrence S; Linglart A; Loche S; Maghnie M; Pérez Sánchez J; Polak M; Predieri B; Richter-Unruh A; Rosenfeld RG; Yeste D; Yorifuji T; Blum WF
J Clin Endocrinol Metab; 2019 Feb; 104(2):379-389. PubMed ID: 30219920
[TBL] [Abstract][Full Text] [Related]
13. Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature.
Strojan P; Popović M; Jereb B
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):65-73. PubMed ID: 10924973
[TBL] [Abstract][Full Text] [Related]
14. Pooled Analysis of Meningioma Risk Following Treatment for Childhood Cancer.
Withrow DR; Anderson H; Armstrong GT; Hawkins M; Journy N; Neglia JP; de Vathaire F; Tucker MA; Inskip PD; Brenner AV; Stovall MA; Diallo I; Berrington de Gonzalez A; Veiga LHS
JAMA Oncol; 2022 Dec; 8(12):1756-1764. PubMed ID: 36201196
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER.
Sävendahl L; Polak M; Backeljauw P; Blair JC; Miller BS; Rohrer TR; Hokken-Koelega A; Pietropoli A; Kelepouris N; Ross J
J Clin Endocrinol Metab; 2021 May; 106(6):1728-1741. PubMed ID: 33571362
[TBL] [Abstract][Full Text] [Related]
16. Long-term mortality after childhood growth hormone treatment: the SAGhE cohort study.
Sävendahl L; Cooke R; Tidblad A; Beckers D; Butler G; Cianfarani S; Clayton P; Coste J; Hokken-Koelega ACS; Kiess W; Kuehni CE; Albertsson-Wikland K; Deodati A; Ecosse E; Gausche R; Giacomozzi C; Konrad D; Landier F; Pfaeffle R; Sommer G; Thomas M; Tollerfield S; Zandwijken GRJ; Carel JC; Swerdlow AJ
Lancet Diabetes Endocrinol; 2020 Aug; 8(8):683-692. PubMed ID: 32707116
[TBL] [Abstract][Full Text] [Related]
17. Therapy-related Secondary Malignancy After Treatment of Childhood Malignancy: Cases from a Single Center.
Ueda T; Migita M; Itabashi T; Tanabe Y; Uchimura R; Gocho Y; Yamanishi M; Kobayashi F; Yoshino M; Fujita A; Yamanishi S; Kaizu K; Hayakawa J; Asano T; Maeda M; Itoh Y
J Nippon Med Sch; 2019 Sep; 86(4):207-214. PubMed ID: 31061250
[TBL] [Abstract][Full Text] [Related]
18. Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
Heymer EJ; Hawkins MM; Winter DL; Teepen JC; Sunguc C; Ronckers CM; Allodji RS; Alessi D; Sugden E; Belle FN; Bagnasco F; Byrne J; Bárdi E; Garwicz S; Grabow D; Jankovic M; Kaatsch P; Kaiser M; Michel G; Schindera C; Haddy N; Journy N; Česen Mazić M; Skinner R; Kok JL; Gunnes MW; Wiebe T; Sacerdote C; Maule MM; Terenziani M; Jakab Z; Winther JF; Lähteenmäki PM; Zadravec Zaletel L; Haupt R; Kuehni CE; Kremer LC; de Vathaire F; Hjorth L; Reulen RC
Br J Cancer; 2024 Apr; 130(6):976-986. PubMed ID: 38243010
[TBL] [Abstract][Full Text] [Related]
19. Childhood ALL and second neoplasms.
Maniar TN; Braunstein I; Keefe S; Hussen S; Abrams T; De Michele A; El-Deiry WS
Cancer Biol Ther; 2007 Oct; 6(10):1525-31. PubMed ID: 17952026
[TBL] [Abstract][Full Text] [Related]
20. Second brain tumors following central nervous system radiotherapy in childhood.
Chojnacka M; Pędziwiatr K; Skowrońska-Gardas A; Perek-Polnik M; Perek D; Olasek P
Br J Radiol; 2014 Sep; 87(1041):20140211. PubMed ID: 24968876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
